UOTTAIMCU
TAK icon

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Takeda Pharmaceutical TAK Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-137
Closed -$2K – 70
2022
Q3 		$2K Buy
+137
New +$1.91K ﹤0.01% 19

Other funds holding TAK

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s TAK Position: Q4 2022 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) sold out of Takeda Pharmaceutical (TAK) in Q4 2022, closing a stake of 137 shares — an estimated $2K sold.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in TAK in Q3 2022 and held it in 1 quarter. The position peaked at $2K in Q3 2022. 282 funds tracked by Wall St. Rank hold TAK as of Q4 2022.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) reported no remaining Takeda Pharmaceutical position as of Q4 2022 after selling out during the quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) sold 137 Takeda Pharmaceutical shares in Q4 2022, an estimated $2K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Takeda Pharmaceutical in Q3 2022 and held it in 1 quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s Takeda Pharmaceutical position peaked at $2K in Q3 2022.
  • 282 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2022.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q4 2022, filed 14 Feb 2023.